Sign In
Buy GNOM
$49.01
+0.96 (+1.99%)
At Close: Jun 03, 2026
GNOM: A Genomics ETF That Will Have Its Day, Even If Not Right Now
04:02am, Sunday, 28'th May 2023
GNOM is a $200 million ETF that invests in a forward-looking set of innovative businesses focused on the genomics industry. This is a long-term growth area, but it will need to get more profitable to
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
09:17am, Saturday, 25'th Mar 2023
CRISPR could revolutionize the way we treat thousands of diseases. Currently, there are about 7,000 caused by genetic disorders, which occur when a mutation affects your genes, or when you have the wr
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
11:31am, Wednesday, 15'th Mar 2023
Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.
Will 2023 be the Year of Cathie Wood ETFs?
09:02am, Tuesday, 24'th Jan 2023
Cathie Wood, famous for the success of Ark Investment???s winning products, had faced a miserable fate in 2022.
GNOM: Healthcare Dashboard For January
09:00am, Thursday, 19'th Jan 2023
Pharmaceuticals and biotechnology have the best value and quality scores in the sector. Healthcare providers are close to their historical baseline in valuation and quality.
GNOM: Get Exposure To The Latest Genomics And Biotechnology Companies
05:16pm, Wednesday, 18'th Jan 2023
The Global X Genomics & Biotechnology ETF tracks the Solactive Genomics Index. It invests in genomics and biotechnology companies. The fund is highly concentrated in one industry, which can negatively
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
03:40pm, Wednesday, 18'th Jan 2023
CRISPR could revolutionize the way we treat thousands of diseases. Many of these diseases occur when mutations affect genes, or when people have the wrong amount of genetic material, the Cleveland
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
GNOM: ETF Review And Healthcare Dashboard For October
07:01pm, Saturday, 15'th Oct 2022
Pharmaceuticals and biotechnology have the best value and quality scores. Healthcare providers look undervalued relative to 11-year averages.
As Biotech Adjusts to “New Normal,” Get Exposure With This ETF
09:06am, Friday, 23'rd Sep 2022
Biotechnology was a much sought-after sector following the pandemic, but it's been having to adjust to a new normal since. Still, the sector offers growth potential as new and innovative biotechnology
Why Now Could Be The Time To Consider Neuroscience Investments
04:45am, Saturday, 27'th Aug 2022
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic
A Comprehensive Guide to Genomic ETFs
12:03pm, Friday, 12'th Aug 2022
Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.
Pharma & Biotech ETFs at One-Month High: Here's Why
09:20am, Friday, 08'th Jul 2022
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
A Comprehensive Guide to Genomic ETFs
05:43pm, Tuesday, 28'th Jun 2022
Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.
GNOM: Poor Historical Performance, Lack Of Focus, Uncertain Future
03:27pm, Thursday, 24'th Mar 2022
GNOM lacks efficient portfolio reshuffling and may not be able to gain from higher alpha-producing stocks in the near future.
